{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:40:30Z","timestamp":1793580030560,"version":"4.5.0"},"reference-count":164,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/14737140.2025.2575825","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T18:02:44Z","timestamp":1760464964000},"page":"43-58","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Drugging the DNA damage response in the clinic: going beyond PARP"],"prefix":"10.1080","volume":"26","author":[{"given":"Carlos","family":"Torrado","sequence":"first","affiliation":[{"name":"The University of Texas, MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Gonzalez-Ortiz","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen de la Victoria","place":["Malaga, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila B.","family":"Xavier","sequence":"additional","affiliation":[{"name":"The University of Texas, MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold N.","family":"Tan","sequence":"additional","affiliation":[{"name":"The University of Texas, MD Anderson Cancer Center","place":["Houston, USA"]},{"name":"National University of Singapore","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Y. L.","family":"Ngoi","sequence":"additional","affiliation":[{"name":"National University of Singapore","place":["Singapore"]},{"name":"National University Cancer Institute","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Yap","sequence":"additional","affiliation":[{"name":"The University of Texas, MD Anderson Cancer Center","place":["Houston, USA"]},{"name":"The University of Texas, MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_238473"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158412"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS5123"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.3154"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-023-01107-3"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2008.2194"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-017-0023-0"},{"key":"e_1_3_5_10_1","doi-asserted-by":"crossref","unstructured":"Kelley MR Wan J Liu S et al. A phase I study targeting the APE1\/Ref-1 redox signaling protein with APX3330: first clinical agent targeting APE1\/Ref-1 in cancer. medRxiv. 2025:2025.04.03.25325173.","DOI":"10.1101\/2025.04.03.25325173"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.169128"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03804-7"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(00)00201-5"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.16.7158-7169.2005"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/35077232"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.102"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.243"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.12.1448"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1289"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1212"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.4.397"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.12.1439"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1129"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/422701"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.2741\/1667"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.03704.x"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3130017"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.12.032"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2018.09.007"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012716"},{"key":"e_1_3_5_31_1","unstructured":"American Association for Cancer Research (AACR). AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma in phase I trial. 2024 [cited 2024 Apr 14]. Available from: https:\/\/www.aacr.org\/about-the-aacr\/newsroom\/news-releases\/azd1390-with-radiotherapy-shows-manageable-safety-profile-and-preliminary-efficacy-for-patients-with-glioblastoma-in-phase-i-trial\/"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-CT171"},{"key":"e_1_3_5_33_1","unstructured":"XRad Therapeutics Inc. Trial of XRD-0394 a kinase inhibitor in combination with palliative radiotherapy in advanced cancer patients. ClinicalTrials.gov [Internet]. U.S. National Library of Medicine. 2025 [cited 2025 Mar 18].Available from: https:\/\/clinicaltrials.gov\/study\/NCT05002140"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01406-w"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.2513"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02404"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.2549"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00406-0"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.780"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30180-7"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02399-0"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae098"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-CT198"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.08.024"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(16)32607-7"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02808-y"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.10.009"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS9161"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.622"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(22)01066-8"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2409"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.3103"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-22-0277"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.3579"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.3581"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.665"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.3062"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-010-9562-8"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2378-9"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.02.018"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2380-5"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.5788"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3131-x"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47215-6"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09138-z"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2020-CT248"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01151-6"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102217"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1129"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.2076"},{"key":"e_1_3_5_71_1","unstructured":"Larvol. Larvol Veri - Peposertib (M3814). Drug and clinical trials database entry. 2025 [cited 2025 Mar 14]. Available from: https:\/\/veri.larvol.com\/trials\/peposertib-m3814\/drug"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110901"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-6093"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0517-3"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2710-1"},{"key":"e_1_3_5_76_1","unstructured":"National Cancer Institute. A study of ART4215 for the treatment of advanced or metastatic solid tumors. 2021 [cited 2025 Feb 8]. Available from https:\/\/www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2021-12675"},{"key":"e_1_3_5_77_1","unstructured":"Targeted Oncology. Phase 2 trial of ART4215 and talazoparib initiated in BRCA deficient breast cancer. 2022 [cited 2025 Feb 23]. Available from: https:\/\/www.targetedonc.com\/view\/phase-2-trial-of-art4215-and-talazoparib-initiated-in-brca-deficient-breast-cancer"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.3005"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0219"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00830"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03167"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00730"},{"key":"e_1_3_5_83_1","unstructured":"Zentalis. Zentalis pharmaceuticals reports third quarter 2023 financial results and operational updates. News release. Zentalis Pharmaceuticals. 2023 [cited 2024 Sep 14]. Available from: https:\/\/ir.zentalis.com\/news-releases\/news-release-details\/zentalis-pharmaceuticals-reports-third-quarter-2023-financial"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.3120"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.3012"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45237-8"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/258427a0"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2514"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.177"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.10.1555"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2012.06.002"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3546"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.12.001"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5442.1162"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003277"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/35018134"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011681200"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.10.029"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.3.463"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg240"},{"issue":"1","key":"e_1_3_5_101_1","first-page":"335","article-title":"Abnormal regulation of DNA replication and increased lethality in ataxia telangiectasia cells exposed to carcinogenic agents","volume":"42","author":"Jaspers NG","year":"1982","unstructured":"Jaspers NG, de Wit J, Regulski MR, et al. Abnormal regulation of DNA replication and increased lethality in ataxia telangiectasia cells exposed to carcinogenic agents. Cancer Res. 1982 Jan;42(1):335\u2013341.","journal-title":"Cancer Res"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S208720"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000276200"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1216824110"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.20.13471"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.852453"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.16.5706-5715.2003"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0358"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2011.02.010"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20080413"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8924(94)90142-2"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1140321"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5395.1893"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1384126"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90458-2"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.12.6623"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e07-06-0525"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2019.1593649"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03097"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.TARG-17-B079"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18728"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100394"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32554-X"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.11525"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00110-7"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0157"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1029"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019183118"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2006.07.033"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210994"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.10.026"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16456"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST20160116"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2007.07.002"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-024-02410-z"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00996"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04638-9"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.TARG-23-PR008"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23463-8"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1080\/07352680701252817"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2016.05.003"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c02101"},{"key":"e_1_3_5_143_1","unstructured":"IDEAYA Biosciences. IDEAYA Biosciences announces clearance of IND Application for Pol theta helicase development candidate GSK101 (IDE705). 2023 [cited 2025 Apr 10]. Available from https:\/\/media.ideayabio.com\/2023-08-21-IDEAYA-Biosciences-Announces-Clearance-of-IND-Application-for-Pol-Theta-Helicase-Development-Candidate-GSK101-IDE705"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108865"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0409"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.10.045"},{"key":"e_1_3_5_147_1","unstructured":"Therapeutics T. Tango Therapeutics announces discontinuation of TNG348 program 2023. 2024. Available from: https:\/\/ir.tangotx.com\/news-releases\/news-release-details\/tango-therapeutics-announces-discontinuation-tng348-program\/"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2019.02.002"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-407696-9.00005-1"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00191"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.11.5.19482"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2017.02.010"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.12.006"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0106"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01778"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-1883"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2019.0097"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00532-x"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-CT007"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040953"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.24.00204"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810858"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903387"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1382-1"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061388"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01435"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2025.2575825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:57:29Z","timestamp":1767592649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2025.2575825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/14737140.2025.2575825"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2025.2575825","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}